Skip to content
healthcare.dev
Get a free key

CARVYKTI

NDC 57894-111, ciltacabtagene autoleucel, injection, suspension, from Janssen Biotech, Inc..

Product NDC
57894-111
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125746
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILTACABTAGENE AUTOLEUCEL100000000 1/1
Package NDCNDC-11Package
57894-111-01578940111011 INJECTION, SUSPENSION in 1 BAG (57894-111-01)
57894-111-02578940111021 INJECTION, SUSPENSION in 1 BAG (57894-111-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-111

Use it

Look up 57894-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.